Stephanie Hass
Business Development Manager Evestia Clinical
Dr. Prichard serves as Evestia Clinical’s Medical Director, providing medical oversight across the company’s clinical trial activities. She has more than a decade of experience in medical monitoring and safety reporting for drug and biologic trials, as well as in the comprehensive review and interpretation of clinical trial data. Dr. Prichard is a trusted resource for Sponsors, offering strategic clinical insight, and supports Evestia internally by providing therapeutic training and guidance to our study teams.
Her clinical research experience spans multiple therapeutic areas, including genetic and rare diseases, oncology, immunology, respiratory, and neurology indications, with a particular focus on neurodegenerative disorders. Dr. Prichard earned her medical degree from the Medical College of Georgia and completed her residency training at the University of Virginia, where she later served as an Assistant Professor. She subsequently practiced as a general pediatrician in a small-town setting, bringing a broad, hands-on clinical perspective to her work in clinical research.
Seminars
Wednesday 3rd June 2026
Panel Discussion: Given Recent Failures, How Can We Tailor ALS Clinical Trials to Successfully Meet Regulatory Expectations
1:40 pm
- Outlining the approval path for sporadic and familial ALS: is it the same for different modalities? What is the regulatory bar for approving this?
- Harnessing innovative trial design
- Cross comparing diverging requirements for different regulatory agencies including the FDA, EMA and more
- Establishing clear, patient-relevant endpoints and leveraging biomarkers to demonstrate efficacy
- Critically identifying stumbling blocks in IND and BLA packages to circumvent late-stage failures and pitfalls in drug development
